Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Clinical trial NCT06643000 · RECRUITING

Trial details

NCT number: NCT06643000
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Leptomeningeal Metastasis EGFR Gene Mutation

Start date: 2024-12-20
Primary completion: 2025-03-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.